What is CytomX Therapeutics's investment proceeds?

CytomX Therapeutics (CTMX) reported investment proceeds of $50M in Q1 2026.

How has CytomX Therapeutics's investment proceeds changed year-over-year?

CytomX Therapeutics's investment proceeds decreased by 1.0% year-over-year, from $50.5M to $50M.

What is the long-term trend for CytomX Therapeutics's investment proceeds?

Over 4 years (2021 to 2025), CytomX Therapeutics's investment proceeds has grown at a 1.8% compound annual growth rate (CAGR), from $124M to $133M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

CytomX Therapeutics CTMX Investment Proceeds

Investment Proceeds at other companies

Janux TherapeuticsJANX

$121.31M+288%

Allogene TherapeuticsALLO

$72.12M+27.6%

Design Therapeutics, Inc.DSGN

$45M-52.4%

ImmunomeIMNM

$0-100%

CelcuityCELC

$50M-25.2%

Vir Biotechnology, Inc.VIR

$170.6M-43.5%

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's investment proceeds?: CytomX Therapeutics (CTMX) reported investment proceeds of $50M in Q1 2026.
How has CytomX Therapeutics's investment proceeds changed year-over-year?: CytomX Therapeutics's investment proceeds decreased by 1.0% year-over-year, from $50.5M to $50M.
What is the long-term trend for CytomX Therapeutics's investment proceeds?: Over 4 years (2021 to 2025), CytomX Therapeutics's investment proceeds has grown at a 1.8% compound annual growth rate (CAGR), from $124M to $133M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.